Singapore Institute of Advanced Medicine Holdings Ltd. (listing name: SAM Holdings) is a healthcare service provider cater to a wide spectrum of diseases and health conditions including, but not limited to, cancer, neurodegenerative and cardiovascular disease detection, and treatment.
The Group is primarily engaged in the following key business segments: